SEC Comment Letter for Tectonic Therapeutic, Inc. (TECX) (CIK 0001681087) (TECX) — Jul 3, 2019
Tectonic Therapeutic, Inc. (TECX) (CIK 0001681087)
Date: July 3, 2019 · CIK: 0001681087 · Accession: 0000000000-19-010742
AI Filing Summary & Sentiment
File numbers found in text: 333-232489
Letter
July 3, 2019 Geoff MacKay President and Chief Executive Officer AVROBIO, Inc. One Kendall Square Building 300, Suite 201 Cambridge, MA 02139 Re:AVROBIO, Inc. Registration Statement on Form S-3 Filed July 1, 2019 File No. 333-232489 Dear Mr. MacKay: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Irene Paik at 202-551-6553 with any questions. Sincerely, Division of Corporation Finance Office of Healthcare & Insurance cc: James Xu - Goodwin Procter LLP
Show Raw Text
July 3, 2019
Geoff MacKay
President and Chief Executive Officer
AVROBIO, Inc.
One Kendall Square
Building 300, Suite 201
Cambridge, MA 02139
Re:AVROBIO, Inc.
Registration Statement on Form S-3
Filed July 1, 2019
File No. 333-232489
Dear Mr. MacKay:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Irene Paik at 202-551-6553 with any questions.
Sincerely,
Division of Corporation Finance
Office of Healthcare & Insurance
cc: James Xu - Goodwin Procter LLP